Boditech Med saw the highest growth of 1.99% in patent filings and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Boditech Med’s patent filings and grants. Buy the databook here.
Boditech Med has been focused on protecting inventions in China(CN) with four publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 25% filings and 75% grants. The United States(US), China(CN), European Patent Office(EPO), and South Korea(KR) patent Office are among the top ten patent offices where Boditech Med is filings its patents. Among the top granted patent authorities, Boditech Med has 75% of its grants in China(CN) and 25% in South Korea(KR).
Fujifilm could be the strongest competitor for Boditech Med
In terms of grant share, Boditech Med stands in sixth position among its competitors. Boditech Med and Fujifilm secured the top positions according to recent patent publication data.
Patents related to climate change and emissions reduction lead Boditech Med's portfolio
Boditech Med has the highest number of patents in climate change followed by, emissions reduction and industrial automation. For climate change no patents were filed and 33% of patents were granted in Q2 2024.
Anesthesia and respiratory devices related patents lead Boditech Med portfolio followed by manufacturing/industrial
Boditech Med has highest number of patents in anesthesia and respiratory devices followed by manufacturing/industrial.
For comprehensive analysis of Boditech Med's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.